Biotechnology stocks are firms that are active in the sector and publicly traded. Biotechnology companies use applied biology for advancements in current methodologies in a variety of industries. The field uses living organisms and bio-processes in many sectors, such as medicine, engineering, agriculture and technology. Since there is a lot of research and development in this sector, small biotech stocks that can develop a new advancement in technology can become very wealthy firms and the stock price can move up sharply. Biotechnology stocks raise money in the public market to help fund this research.
In searching for the top biotech stocks to watch in 2015, let’s not forget that many on Wall Street are talking about the group’s sky-high valuations. In fact, since the start of 2012, the NASDAQ Biotechnology index has gained 256%. In the same period, the S&P 500 has only mustered a 65% gain.
With that in mind, it’s important to do proper due diligence on any biotech stocks in 2015…. Read More
With indecisive stock market action, biotechnology stocks continue to show their speculative strength. It’s a market sector that continues to be very strong, albeit highly speculative.
Of course, where there’s growth, there are also higher valuations and many of the large-cap biotechnology and pharmaceutical companies are richly valued…. Read More
One of the hottest areas of the stock market over the last few years has been one of its most speculative. Biotechnology stocks, as evidenced by the NASDAQ Biotechnology Index, have been on a tear for the last three years.
This index was 1,000 at the end of 2011; it was 1,500 by the beginning of 2013; and now, it’s just shy of 3,200 for an all-time record-high…. Read More
One of the problems with pure-play biotechnology stocks is that they are 100% risk-capital securities in which the probability of success is entirely beyond your control.
But healthcare and related industry investments are very much worthwhile in an equity market portfolio for the simple reason that they can be so profitable.
One company that serves the healthcare industry, but isn’t a pure-play drug discovery enterprise, is Bio-Reference Laboratories, Inc…. Read More
The stock market has an underlying strength to it, seemingly only to be undone by geopolitical events. Fed action always has the potential to shock the system. Negative economic news isn’t fazing this market.
On the back of a pretty decent second quarter, many corporate outlooks predict another year of decent growth, particularly with earnings…. Read More